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1. Introduction 
Biomarkers used fo r clinical testing of certa in types of can­
cer are specific proteins such as prostate-specific antigen (PSA) 
(for prostate cancer). carcinoma antigen 125 (eA 125) (for ovar-
ian cancer), cancer antigen 15-3 (eA 15-3) (for breast cancer), 
and carcinoembryonic antigen (CEA) (for colon cancer ). Devel­
opment of sensitive detection techniques for the detect ion of 
low-concentration cancer biomark€'rs present in the early stage of 
thedisease is crucial for the outcome ofthe treatment ofthe disease 
(Rasooly and Jacobson, 2006; Warsinke, 2009), Electrochemical 
immunosensors appear to be a suitable platform for establishing 
biomarker detection techniques (Wang, 2006). In particular, since 
they allow fast real-time measurements and device miniaturiza­
tion. electrochemical immunosensors are potentially suitable for 
the point-oF-care approach to biomarker assay (Warsinke, 2009). 
Recent development in the detect ion of biomarkers includes 
several noted works. In a bio-barcode assay for PSA (Thaxton 
et .11.. 2009). gold nanoparticles. functionalized with DNA and PSA­
specific antibodies. were used to interact through immuno-reaction 
with magnetic microparticles that had been first functionalized 
with PSA-specific antibodies and subsequently mixed with the 
serum sample containing the PSA target. After magnetic sep­
aration, the PSA-specific DNA barcodes were released into a 
solution and detected using scanometric assay. The detection 
limit of this bio-barcode PSA assay was 330fg/ml serum. An 
amperometric immunosensor for the simultaneous detection of 
two cancer biomarkers has been constructed on two iridium 
oxide electrodes ( I-mm diameter) patterned on a glass sub­
strate (Wilson. 2005). Capture antibodies were immobilized on 
the porous iridium oxide electrodes by covalent attachment using 
(3-aminopropyl) triethoxysilane and glutaraldehyde. The spa­
tial separation of the electrodes (2.5 mm) enabled simultaneous 
electrochemical immunoassays ofCEA and o:-fetoprotein to be con­
ducted without cross-talk between the electrodes. The biomarkers 
were measured using electrochemica l ELISA, and detection was 
achieved by e lect rochemically oxidizing alkaline phosphatase­
generated hydroquinone. The sensor had detection limits of 1.2, 
and I nglml for CEA and o:-fetoprotein. respectively. A novel CA 
125 immunosensor was prepared by co-immobilization orCA 125 
and thionine, which was used as an electron transfer mediator, on 
a modified carbon electrode (Wu et aI., 2007). Antibodies labeled 
with horseradish peroxidase (HRP) were used to bind CA 125 via 
immuno-conjugation. Hydrogen peroxide (HzOz), the substrate of 
HRP, was released to the sensor, and CA 125 was detected by mea­
suring the electrode current produced due to the HRP-catalyzed 
reduction of H20 2. The sensor showed a linear range of 2-75 U/m l 
and a detection limit of 1.8 U/ml. 
Recently, a novel field -effect enzymat ic detect ion (FEED) tech­
nique, in which an external gating voltage was used to induce an 
electric field at the enzyme-electrode interface to amplify the sig­
nal current of an enzyme-based biosensor, has been developed 
(Choi and Vau, 2009). This technique was used to lower the detec­
tion limit of molecular analytes from the milli-molar (10- 3M) 
level obtained in the absence of the gating voltage down to the 
pico-molar (10- 12 M) level achieved when the gating voltage was 
             
            
           
               
               
           
               
  
      
         
       
         
        
         
         
           
         
        
         
        
        
        
          
        
         
          
         
          
          
         
   
         
          
      
     
         
        
            
         
          
         
          
         
         
              
           
          
         
      
        
          
          
           
          
             
           
          
          
        
            
         
          
          
          
         
         
             
          
          
         
         
          
         
         
            
           
         
       
          
           
         
           
           
       
            
      
         
        
        
       
   
        
        
       
        
          
        
        
      
        
        
        
          
         
             
          
Fig. 1. A cross-sectional view of the detection system. The PG electrode with the
multilayers of materials deposited on it depicts the structure of the detecting elec-
trode. The gating electrodes are representedby the circular structures,which consist
of a copper wire (the blue circles) and a thin layer of insulator (the shaded shells
made of enamel). The gating voltageVG is used to induce an electric ﬁeld at the inter-
face between the sample solution and the detecting electrode. (For interpretation of
the references to color in this ﬁgure legend, the reader is referred to theweb version
of the article.)
applied. Compared to the conventional ﬁeld-effect-transistor (FET)
biosensor, which employs the FET to provide a reference current,
the FEED technique features a voltage-controlled ampliﬁcation of
the signal current. The signal current is produced by quantum
tunneling of electrons, which depends critically on the distance
electrons travel by means of tunneling and the potential energy
proﬁle of the tunnel structure. The FEED technique allows the
energy proﬁle of the tunnel structure to be changed using the gat-
ing voltage to increase the electron transfer rate. Therefore, the
main advantage of the new technique is the voltage-controlled
ampliﬁcation of the signal current. In the work reported here,
the FEED technique was applied to the enzyme-linked ampero-
metric immuno-sensing scheme and the feasibility of using this
new detection approach as a biomarker detection technique was
demonstrated by the detection of the biomarker CA125, using elec-
trodes modiﬁed with carbon nanotube. The incorporation of the
twodetectionmethodshas resulted in a reagentless assay approach
(Wang, 2005;Weiss et al., 2007), another advantage of the reported
technique, which does not use electron transfer mediators and the
substrate of the enzyme used to label the secondary antibody. As
the result of the signal ampliﬁcation, the detection limit of the
detection system was lowered from 4.9U/ml to 0.9U/ml.
2. Materials and methods
Fig. 1 shows a cross-sectional view of the detection system
used in the experiment. The detection system consists of a conven-
tional three-electrode (counter electrode, reference electrode and
working/detecting electrode) electrochemical cell modiﬁed with
additional gating electrodes for applying a gating voltage VG to the
detecting (working) electrode. A piece of 0.5mm-diameter copper
wire coatedwith a thin layer of insulator (enamel)was bent to form
a U-shaped structure and was attached on the detecting electrode
close to the exposed area using nonconductive epoxy as the gat-
ing electrode. A variable dc power supply was connected between
the gating electrode and the detecting electrode to provide the gat-
ing voltage VG. The principle of the ﬁeld-effect enzymatic detector
is described previously (Choi and Yau, 2009). Disks of pyrolytic
graphite (PG) (1 cm×1 cm)wereusedas thebasic electrode. ThePG
electrodewasmodiﬁed ﬁrstwith a thin layer of Naﬁon (Naﬁon 117,
Fluka). The Naﬁon membrane was used to enhance the binding of
the nanotube layer to the PG electrode. Single-walled carbon nan-
otubes (Carbon Solutions) were dissolved in dimethylformamide.
The nanotube solution was then mixed with 1% glutaraldehyde
solution (Sigma–Aldrich) and a drop of the mixture was placed on
theNaﬁon layer tohost thebiomarker. Thepreparationof nanotube
solution and its handling were carried out in a chemical hood in
order to eliminate exposure to aerosol release. A mask was used
to expose a 0.5mm×0.5mm area of the modiﬁed PG electrode.
An 8�l drop of a solution containing CA-125 (CA-125 ELISA, Sig-
nosis), the analyte, was deposited on the exposed area and the
electrode was incubated for 22h, after which the electrode was
rinsed with de-ionized water. The detecting electrode was formed
by placing a 25�l drop of solution containing 1ng/ml of antibody
labeled with HRP (CA-125 ELISA, Signosis) on the exposed area
and incubating the electrode for 45min. The same antibody con-
centration (1ng/ml) was used for the incubation of all electrodes.
The CA 125 antibody was monoclonal and has an afﬁnity constant
of 1.0×109 M−1 (Boerman et al., 1990). This protein immobiliza-
tionmethod has been used to immobilized other biomarkers (Bollo
et al., 2007; Yu et al., 2005). The antibodywas bound to CA-125 due
to immuno-reaction. In Fig. 1, the PG electrodewith themultilayers
of materials deposited on it depicts the structure of the detect-
ing electrode. The advantage of immobilizing the antigen on the
electrode without using the primary antibody is that the passage
for electron transfer from the enzyme used to label the secondary
antibody to the electrode is shortened and therefore signal cur-
rent is increased. Note that without nanotubes the signal would
become weak. This is likely to be due to the better electrical con-
ductivity provided by the nanotubes and the fact that CA 125 was
immobilized on the electrode by being entrapped in the nanotubes.
Voltammetric (cyclic and linear) measurements were made to
obtain the detection signal. A commercial Ag/AgCl (3M KCl) elec-
trodewas used as the reference electrode, and a platinumwirewas
used as the counter electrode. The volume of the electrochemical
cell was 1ml. The cell was driven by a commercial electrochemical
controller (CHI 660CWork Station). A potential scan rate of 50mV/s
was used in recording voltammograms. Phosphate buffer solution
(PBS, 0.1MatpH7)waspreparedusingde-ionizedwater (18.2M-
cm). Commercially available hydrogen peroxide (Fisher scientiﬁc,
30% concentration) was diluted to the concentrations used in the
experiment andwas stored in plastic containers. Allmeasurements
weremadewith deaerated PBS at room temperature. Reproducible
results were obtained by repeating each measurement multiple
times.
3. Results and discussion
In carrying out the detection, control experiments have been
performed repeatedly using different types of electrode in order
to avoid possible misinterpretation of the measurement results.
Fig. S1(a) shows several cyclic voltammograms (CVs), which are
used to validate the detection signal of CA-125. The CVs were
obtained in PBS under different electrode conditions. CV1 was
obtained with a modiﬁed PG electrode, upon which CA-125
(200U/ml) was immobilized. The CA-125-immobilized electrode
was then incubated with the HRP-labeled antibody and then
rinsed with de-ionized water. The electrode now contained the
antigen–antibody immuno-structureon its surfaceand it is referred
to as the detecting electrode. CV2 was obtained with the detecting
electrode.CV1 is featurelesswhileCV2showsan increasedcharging
current and a pair of redox peakswith a formal potential of −0.42V
and a peak-to-peak separation of 20mV. Previous works on the
        
           
             
         
         
       
        
        
          
          
            
        
       
         
          
         
         
           
          
          
       
   
      
          
         
     
        
         
         
       
          
             
       
         
        
       
        
        
         
           
          
       
          
         
          
          
         
            
         
            
            
         
          
          
         
            
         
           
          
           
           
           
        
          
            
             
          
           
            
                 
            
     
            
          
         
         
          
            
         
        
          
direct electron transfer associatedwith immobilizedHRP showthat
the formal potential of this redox process is between −0.5V and
−0.35V vs. Ag/AgCl (Ferri et al., 1998; Zhang et al., 2004). Thus, the
redox peaks in CV2 indicate the occurrence of the immunological
binding between CA-125 and its antibody and, therefore, the pres-
ence of the antigen–antibody immuno-structure on the electrode.
The small peak-to-peak separation of 20mV indicates reversible
interfacial electron transfer. The increased charging current is also
consistent with the presence of the antibody on the electrode since
the antibody has increased the effective area of the electrode sur-
face exposed to the solution as shown in Fig. 1. To eliminate the
possibility that residual unbound antibody on the electrode may
generate signal, HRP-labeled antibody (1ng/ml) was immobilized
on the modiﬁed electrode, the electrode without the presence of
CA-125, andCVswereobtained. CV3,whichwasobtainedwith such
electrode, is featureless without the presence of the redox peaks.
The reduced charging current compared to CV2 is consistent with
the absence of CA-125 on the electrode. CV4 shows that the redox
signal becomes weak if carbon nanotubes are not used. Note that
carbon nanotubes rather than carbon powder was used due to the
signiﬁcantly smaller electrical resistivity (Chiodarelli et al., 2011;
Nakazawaa et al., 2004).
Alternatively, the immunological binding was conﬁrmed by
testing the enzymatic activity of HRP. Fig. S1(b) shows four CVs
obtained using a detecting electrode (200U/ml of CA-125), an
electrode containing the antigen–antibody immuno-structure, in
different concentrations of H2O2. The electrode responds to H2O2
by progressively increasing the cathodic current due to the reduc-
tion of H2O2 catalyzed by HRP. On the contrary, such response
to H2O2 was not observed using a CA-125-immobilized electrode.
Note that although the CVs show very weak and broadened redox
peaks as indicated by the arrows or no peaks at all, the fact that
the electrode’s cathodic current responds to H2O2 indicates the
enzymatic activity of HRP as previously observed (Andreu et al.,
2007).
For the detection of CA-125, modiﬁed electrodes that have
been incubated with solutions containing different CA-125 con-
centrations and subsequently incubated with the same amount of
HRP-labeled antibody (1ng/ml) were used as detecting electrodes.
The detection signal was obtained by measuring the peak current
of the reduction peak of HRP in the linear voltammograms (LVs) of
different detecting electrodes. Fig. 2(a) shows the LVs of 3 detecting
electrodes,whichwere incubatedwithdifferentCA-125concentra-
tions, obtained in the absence of the gating voltage. The reduction
peak currents were determined using the baseline displayed in the
ﬁgure. The LVs show that as the CA-125 concentration is increased,
the reduction peak current increases. The inset in Fig. 2(a) shows
the CA-125 calibration curve of the detection systemobtainedwith
different detecting electrodes, i.e. 3, 7, 15, 50, 100, 200U/ml, in the
absence of the gating voltage. The detection limit was estimated
to be 4.9U/ml, using the signal/noise =3 method. The curve shows
that the 3 and 7U/ml data points almost coincide with each other.
The effect of applying VG on the detection signal was studied
and it was found that the reduction-peak current increased as VG
was increased. Fig. 2(b) shows four LVs obtained with a detect-
ing electrode, which has been incubated with 200U/ml CA-125.
The four CVs were obtained with VG =0, 0.1, 0.2, 0.3V, respectively,
and the corresponding peak currents of the reduction peaks are
0.04, 0.3, 0.4, and 0.58�A as measured using the baseline. Previ-
ously, the increase in the signal current of the bio-detector, which
is used in this work, caused by applying VG in the positive polarity
was attributed to the reduction of the height of the tunnel bar-
rier between the active site of the enzyme and the electrode. VG
induces an electric ﬁeld at the enzyme–electrode interface, and
the ﬁeld reduces the effective height of the tunnel barrier, result-
ing in an increase in the tunnel rate of electrons (Choi and Yau,
Fig. 2. (a) LVs of 3 detecting electrodes, whichwere immobilizedwith different CA-
125 concentrations. The reduction peak currents are indicated using the baseline.
Inset: the calibration curve of detection of CA-125 obtainedwith different detecting
electrodes. (b) Four LVs obtained with a detecting electrode, which has been incu-
batedwith200U/mlCA-125. TheLVswereobtainedwithVG =0, 0.1, 0.2, 0.3V. (c) The
effect of increasing VG in the negative polarity on the signal current is demonstrated
with a larger 200U/ml electrode.
2009; Tans et al., 1998). It is believed that the same mechanism is
responsible for the observed increase in the signal current in the
present work. An evidence for this mechanism was observed by
reversing the polarity of VG. A negative VG reverses the direction
of the induced ﬁeld and therefore increases the effective height of
the tunnel barrier (Snow et al., 1988). Fig. 2(c) shows the effect of
increasing VG in the negative polarity on the signal current. The
LVswere obtainedwith progressively increasing VG in the negative
polarity. The decrease in the signal current appears to be obvious
                        
                          
                           
            
     
           
           
      
       
         
       
        
        
             
          
         
           
          
          
          
         
         
            
          
    
       
        
         
            
             
          
          
           
        
           
            
                
Fig. 3. (a) The dependences of the ampliﬁcation of signal current on VG for two detecting electrodes immobilized with different CA 125 concentrations. (b) The calibration
curves of the detection system for CA 125 at different values of VG . The curve is plotted using six detecting electrodes immobilized with different CA 125 concentrations,
namely, 3U/ml, 7U/ml, 15U/ml, 50U/ml, 100U/ml, and 200U/ml. (c) Plots of the detection limit and sensitivity of the detection system vs. VG .
with the aid of the baseline. The decrease in the signal supports the
scenario of a modiﬁed tunnel barrier.
The increase of the signal current as shown in Fig. 2(b) indicates
that the detection signal is ampliﬁed by varying VG. Fig. 3(a) shows
the voltage-controlled signal ampliﬁcations observed with two
detecting electrodes incubated with solutions of different CA-125
concentrations. Both curves show that as VG is increased, the signal
current increases. In particular, the ampliﬁcation curves (includ-
ing those obtained with electrodes incubated with other CA-125
concentrations) show a slightly nonlinear increase as VG is increase
from 0.2V to 0.3V. This effect reﬂects the fact that the ampliﬁca-
tion indicated by each curve is caused by the same mechanism,
the modiﬁed tunnel barrier, while the difference between the sig-
nal magnitudes of the curves is due to the presence of different
amount of CA-125. The double-arrow sign in Fig. 3(a) indicates that
the ampliﬁcation is controlled reversibly by VG. Note that if VG is
increased beyond 0.3V, the signal current will show a reversible
inverse dependence on VG, which is explained previously in terms
of reversible re-orientation of the enzyme molecule on the elec-
trode by the induced ﬁeld (Choi and Yau, 2011). In the present case,
ﬁeld-initiated reorientation of the antigen, CA125, is also a possible
cause for the effect described.
The ampliﬁcation of the detection signal has signiﬁcantly
improved the performance of the detection system. The detection
system’s calibration curves for CA 125 obtained with different val-
ues of VG using six detecting electrodes (3, 7, 15, 50, 100, 200U/ml)
are shown in Fig. 3(b). Curve 1, obtained for VG =0V and shown
in Fig. 2(a), is displayed here for comparison. Curves 2–4 were
obtained with different values of VG as indicated in the ﬁgure. All
curves show a linear region for low CA 125 concentrations and a
saturation region at higher concentrations. Since the linear regions
of Curve 1 and Curve 2 are virtually determined by two points,
we discuss curve ﬁtting details for Curve 3 and Curve 4 only. The
regression equation used is y=bx+ a, where b is the slope and a is
            
              
         
            
            
          
         
         
         
           
            
               
            
          
           
            
           
     
 
         
        
       
         
         
        
         
          
        
         
       
         
        
 
       
       
  
   
         
    
             
            
    
         
             
         
 
        
        
          
            
    
        
            
      
           
            
            
     
      
       
           
      
           
           
          
the y intercept. In particular, y=0.03078x+0.41636 was used for
Curve 3 and y=0.03415x+0.97441 was used for Curve 4. The cor-
relation coefﬁcients for the two curves are 0.84517 and 0.85783,
respectively.
As stated above, in the absence of VG, the CA 125 detection limit
is 4.9U/ml. The curves show that as VG is increased, the signal cur-
rent level increases. In particular, the current span of the linear
range becomes wider accompanied with an increase in its slope.
Comparing the linear range of the curves shows that VG improves
the detection limit, detection resolution and the sensitivity of the
detection system. As the result of increasing VG to 0.3V, the detec-
tion limit is lowered to 0.9U/ml and the detection system is able
to detect 3U/ml CA 125. The error bar of the 3U/ml data point is
clearly separated from that of the 7U/ml data point. Fig. 3(c) shows
the dependences of the sensitivity and the detection limit of the
detection system on VG. The sensitivity is increased from 1 to about
15nA/Uml−1 as VG is increased from 0 to 0.3V. The 5-fold increase
in sensitivity is signiﬁcant since it causes the detection limit to be
lowered from 4.9 to 0.9U/ml.
4. Conclusions
The present work has demonstrated that the application of the
gating voltage has caused reversible ampliﬁcation of the detec-
tion signal of a modiﬁed amperometric immuno-detection system.
The ampliﬁcation has in turn improved the performance of the
detection system in terms of lowering the detection limit, increas-
ing the detection resolution and detection sensitivity. The method
used to prepare the detecting electrodes indicates that the detec-
tion approach can be used as a general assay methodology for
biomarkers. The low detection limit obtainable via the applica-
tion of VG makes the detection method particularly suitable for the
early detection of cancer recurrence. Additionally, the reagentless
approach, in which nomediators or enzyme substrates is required,
is compatible with the requirement for point-of-care approach of
biomarker assay.
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